NanoString Technologies (NSTG) – Company Press Releases
-
NanoString Announces Completion of Financing to Support Restructuring Process
-
NanoString Takes Steps to Restructure Its Business and Protect Its Mission to Map the Universe of Biology
-
NanoString Launches the CosMx 6,000 plex RNA Assay and Showcases Whole Transcriptome Imaging Capability
-
NanoString’s CosMx SMI Achieves Whole Transcriptome Imaging at Single-Cell Resolution
-
NanoString Reports Inducement Grants Under Nasdaq Listing Rules
-
NanoString to Webcast Presentation from 42nd Annual J.P. Morgan Healthcare Conference
-
NanoString Comments on Delaware District Court Verdict
-
10x Genomics Wins Another Patent Infringement Case Against NanoString Technologies
-
NanoString Technologies to Present Portfolio of Cutting-edge Brain Research and Novel Spatial Biology Applications for Neuroscience
-
NanoString to Webcast Presentations from Upcoming Healthcare Conferences
-
NanoString Technologies Releases Operating Results for Third Quarter of 2023
-
NanoString Customers Present First Data Using the Most Comprehensive Spatial Proteomics Panel Available
-
10x Genomics Comments on Second UPC Preliminary Injunction Decision
-
NanoString Provides Preliminary Financial and Operational Highlights for Third Quarter of 2023
-
A*STAR’s Genome Institute of Singapore, NanoString and Next Level Genomics Establish Joint Lab to Advance Studies of Complex Diseases with Spatial Genomics
-
10x Wins Injunction From Unified Patent Court Banning Sales of NanoString's CosMx Products in Europe
-
NanoString Comments on Unified Patent Court Order
-
NanoString to Host Virtual Spatial Genomics Summit September 19
-
NanoString Launches the Most Comprehensive Spatial Proteomics Panel Ever Offered
-
NanoString Expands Partnerships with Contract Research Organizations Making Spatial Molecular Imaging Tools Widely Available to Global BioPharma Researchers
-
NanoString to Webcast Presentations from Upcoming Healthcare Conferences
-
NanoString Appoints Todd Garland as Chief Commercial Officer
-
NanoString Platforms Advance Groundbreaking Studies of Immune Response in Pig-to-Human Organ Transplants
-
NanoString to Webcast Presentations from Upcoming Healthcare Conferences
-
NanoString Technologies Releases Operating Results for Second Quarter of 2023
-
Delaware District Court Permits NanoString’s Counterclaims that 10x Genomics and Harvard Violated the Antitrust Laws
-
NanoString Provides Preliminary Financial and Operational Highlights for Second Quarter of 2023
-
NanoString Reports Inducement Grants Under Nasdaq Listing Rules
-
NanoString Reports Inducement Grants Under Nasdaq Listing Rules
-
Acrobat Genomics, NanoString, and Illumina Accelerator Collaborate with Stanford Medicine to Discover New Drug Targets for Gene Editing-Based Therapeutics
-
Owkin Powers a New Era in Oncology Research with MOSAIC – An Unprecedented $50 Million Spatial Atlas of Cancer Cells
-
10x Genomics Files Two New Lawsuits Requesting Preliminary Injunctions Against NanoString's CosMx Products
-
NanoString to Webcast Presentation from Jefferies Healthcare Conference
-
NanoString to Host Conference Call on Monday, May 22, 2023, to Provide Comments on Decision of the Regional Court of Munich
-
NanoString Responds to Decision of the Regional Court of Munich
-
10x Genomics Wins Permanent Injunction Against NanoString's CosMx Products
-
NanoString Technologies Releases Operating Results for First Quarter of 2023
-
NanoString to Release First Quarter 2023 Operating Results and Host Conference Call on Wednesday, May 3, 2023
-
NanoString Reports Inducement Grants Under Nasdaq Listing Rules
-
NanoString to Webcast Panel on AI-Based Genomics and Drug Discovery from the 43rd Annual Cowen Health Care Conference
-
NanoString to Webcast Panel on AI-Based Genomics and Drug Discovery from the 43rd Annual Cowen Health Care Conference
-
NanoString Technologies Releases Fourth Quarter and Full Year 2022 Operating Results and Provides 2023 Financial Outlook
-
NanoString to Webcast Presentation from the 43rd Annual Cowen Health Care Conference
-
NanoString to Release Fourth Quarter and Fiscal Year 2022 Operating Results and Host Conference Call on Tuesday, February 28, 2023
-
NanoString Showcases Ultra High-Plex 6K RNA Single Cell Imaging at the 2023 Advances in Genome Biology and Technology (AGBT)
-
Weill Cornell Medicine and NanoString Collaborate to Create Comprehensive Spatial Atlas of Human Anatomy
-
NanoString Releases Single Cell Spatial Transcriptomics Dataset Highlighting Data Quality of CosMx Spatial Molecular Imager
-
NanoString Provides Preliminary Financial and Operational Highlights for Fourth Quarter and FY 2022
-
National Geographic Highlights Use of the CosMx Spatial Molecular Imager in Alzheimer’s Disease Research
-
NanoString to Present at the 41st Annual J.P. Morgan Healthcare Conference
Back to NSTG Stock Lookup
